Debra A Goldman

4PUBLICATIONS
20CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Data security and protectionPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 20, 2024
Early On-Treatment Assessment of T Cells, Cytokines, and Tumor DNA with Adaptively Dosed Nivolumab + Ipilimumab: Final Results from the Phase 2 ADAPT-IT Study.

James W Smithy, Hannah L Kalvin, Fiona D Ehrich

|Dec 20, 2021
Adaptive Dosing of Nivolumab + Ipilimumab Immunotherapy Based Upon Early, Interim Radiographic Assessment in Advanced Melanoma (The ADAPT-IT Study).

Michael A Postow, Debra A Goldman, Alexander N Shoushtari

|Dec 17, 2020
Electronic Medical Record Documentation and Provider Burnout.

Debra A Goldman, Katherine S Panageas

|Jun 20, 2017
High-Grade Serous Ovarian Cancer: Associations between BRCA Mutation Status, CT Imaging Phenotypes, and Clinical Outcomes.

Stephanie Nougaret, Yulia Lakhman, Mithat Gönen

Pageof 1

Frequent Collaborators

2 joint publications

James W Smithy

2 joint publications

Michael A Postow

2 joint publications

Jedd D Wolchok

2 joint publications

Paul B Chapman